Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Julia Rawlings

Concepts (55)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Safety Management
2
2018
126
0.630
Why?
Patient Safety
2
2018
334
0.520
Why?
Pharmacy Service, Hospital
1
2018
84
0.510
Why?
Organizational Culture
1
2018
162
0.490
Why?
Remote Consultation
1
2022
59
0.180
Why?
Drug Overdose
1
2022
356
0.140
Why?
Pharmacy
1
2017
31
0.130
Why?
Pharmaceutical Services
1
2017
83
0.120
Why?
Benchmarking
1
2017
179
0.120
Why?
Opioid-Related Disorders
1
2022
562
0.110
Why?
Pharmacists
1
2017
255
0.110
Why?
Colchicine
1
2012
23
0.100
Why?
Gout Suppressants
1
2012
21
0.100
Why?
Hematologic Diseases
1
2012
66
0.090
Why?
Gout
1
2012
38
0.090
Why?
Chemical and Drug Induced Liver Injury
1
2012
138
0.090
Why?
Renal Insufficiency
1
2012
169
0.080
Why?
Delivery of Health Care
1
2017
949
0.080
Why?
Attitude of Health Personnel
1
2018
1175
0.080
Why?
Cross-Sectional Studies
2
2018
5645
0.080
Why?
Surveys and Questionnaires
2
2018
5931
0.070
Why?
Endrin
1
2022
13
0.050
Why?
Sumatriptan
1
1999
6
0.040
Why?
Health Maintenance Organizations
1
1999
105
0.040
Why?
Colorado
2
2022
4597
0.040
Why?
Migraine Disorders
1
1999
106
0.030
Why?
Pain
1
2022
776
0.030
Why?
Pharmacies
1
2017
39
0.030
Why?
Analgesics, Opioid
1
2022
1114
0.030
Why?
Counseling
1
2017
395
0.030
Why?
Practice Patterns, Physicians'
1
2022
1328
0.030
Why?
Humans
5
2022
140898
0.030
Why?
Cytochrome P-450 CYP3A Inhibitors
1
2012
18
0.020
Why?
Cytochrome P-450 CYP3A
1
2012
89
0.020
Why?
Insurance, Health, Reimbursement
1
2012
97
0.020
Why?
Drug Interactions
1
2012
403
0.020
Why?
Communication
1
2017
948
0.020
Why?
Enzyme Inhibitors
1
2012
842
0.020
Why?
United States
2
2022
15195
0.020
Why?
Prevalence
1
2012
2780
0.010
Why?
Case-Control Studies
1
2012
3578
0.010
Why?
Electronic Health Records
1
2012
1125
0.010
Why?
Cohort Studies
1
2012
5789
0.010
Why?
Efficiency
1
1999
101
0.010
Why?
Health Services
1
1999
115
0.010
Why?
Statistics, Nonparametric
1
1999
432
0.010
Why?
Cost of Illness
1
1999
310
0.010
Why?
Young Adult
1
2012
13646
0.010
Why?
Middle Aged
2
2012
34487
0.010
Why?
Patient Satisfaction
1
1999
690
0.010
Why?
Adult
2
2012
39134
0.010
Why?
Aged
1
2012
24666
0.010
Why?
Male
2
2012
69893
0.000
Why?
Female
2
2012
75540
0.000
Why?
Quality of Life
1
1999
3005
0.000
Why?
Rawlings's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)